SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001801198-23-000026
Filing Date
2023-11-20
Accepted
2023-11-20 06:02:20
Documents
94
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 6-K legn-20230930.htm   iXBRL 6-K 802252
2 EX-99.1 a991earningsreleaseq32023s.htm EX-99.1 165209
3 EX-99.4 pipelineq32023.htm EX-99.4 608
9 legendlogoa.jpg GRAPHIC 6967
10 pipelineq32023001.jpg GRAPHIC 144769
  Complete submission text file 0001801198-23-000026.txt   5505159

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT legn-20230930.xsd EX-101.SCH 79434
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT legn-20230930_cal.xml EX-101.CAL 87794
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT legn-20230930_def.xml EX-101.DEF 165720
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT legn-20230930_lab.xml EX-101.LAB 560861
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT legn-20230930_pre.xml EX-101.PRE 362440
88 EXTRACTED XBRL INSTANCE DOCUMENT legn-20230930_htm.xml XML 696495
Mailing Address 2101 COTTONTAIL LANE SOMERSET NJ 08873
Business Address 2101 COTTONTAIL LANE SOMERSET NJ 08873 732-317-5050
Legend Biotech Corp (Filer) CIK: 0001801198 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39307 | Film No.: 231420627
SIC: 2834 Pharmaceutical Preparations